User contributions for Lazy

From Glioblastoma Treatments
A user with 467 edits. Account created on 16 March 2024.
Jump to navigationJump to search
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽
(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

29 September 2024

13 August 2024

12 August 2024

13 June 2024

29 May 2024

27 May 2024

17 May 2024

  • 19:1219:12, 17 May 2024 diff hist +3,163 N Metronomic low dose temozolomide (TMZ)Created page with "{{TreatmentInfo |drug_name=Metronomic Low-Dose Temozolomide (TMZ) |FDA_approval=FDA-approved for glioblastoma but standard metronomic dosing is still under investigation |used_for=Glioblastoma Multiforme (GBM), recurrent GBM |clinical_trial_phase=Phase II and III for metronomic dosing schedules |common_side_effects=Nausea, vomiting, fatigue, myelosuppression, lymphopenia |OS_without=Median overall survival for GBM is typically 15-17 months from diagnosis |OS_with=Studies..." current
(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)